Nicox’s NCX 470 Hits Phase III Endpoint In Glaucoma But Misses Superiority

 
• By Joseph Haas
Glaucoma model
Nicox is looking to enter the very competitive glaucoma therapeutic space • Source: Shutterstock

More from Clinical Trials

More from R&D